The effects of the administration of subfacial levobupivacaine infusion with the ON-Q pain pump system on postoperative analgesia and tramadol consumption in cesarean operations

Basit Öğe Kaydı
dc.contributor.authorTuncer, Sema
dc.contributor.authorAysolmaz, Gokhan
dc.contributor.authorReisli, Ruhiye
dc.contributor.authorErol, Atilla
dc.contributor.authorYalcin, Naime
dc.contributor.authorYosunkaya, Alper
dc.date.accessioned2024-02-23T14:45:31Z
dc.date.available2024-02-23T14:45:31Z
dc.date.issued2010
dc.departmentNEÜen_US
dc.description.abstractObjectives: In this study, the effects of administration of subfacial levobupivacaine infusion with the ON-Q pain pump system were investigated in elective cesarean operations for postoperative pain control and tramadol-sparing effect. Methods: Fifty ASA I-II patients scheduled for cesarean operation were enrolled into this study. Patients were randomly divided into two groups: Group I served as a control group, without the ON-Q pain pump system, whereas Group II received the ON-Q pain pump system with subfacial 0.25% levobupivacaine infusion for 24 hours at 4 ml/hour. All patients received a standard anesthetic protocol. At the end of the surgery, all patients received tramadol i.v. via a PCA (Patient Controlled Analgesia) device. Pain scores were assessed at 2, 6, 12 and 24 hours postoperatively. Tramadol consumption and adverse effects were noted in the first 24 hours following surgery. Results: The pain scores were significantly lower in the levobupivacaine group when compared with the control group (p<0.05). The cumulative tramadol consumption was lower in the levobupivacaine group than in the control group (p<0.05). Group II used less antiemetic and had less postoperative nausea and vomiting, and the difference was statistically significant (p<0.05). Conclusion: No complication occurred as a result of the ON-Q pain pump system. Subfacial levobupivacaine infusion with the ON-Q pain pump system diminished postoperative pain and the need for tramadol use following cesarean operations.en_US
dc.identifier.endpage78en_US
dc.identifier.issn1300-0012
dc.identifier.issue2en_US
dc.identifier.pmid20582749en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage73en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12452/17462
dc.identifier.volume22en_US
dc.identifier.wosWOS:000421061200005en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isotren_US
dc.publisherKare Publen_US
dc.relation.ispartofAgri-The Journal Of The Turkish Society Of Algologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectLevobupivacaineen_US
dc.subjectOn-Q Pain Pump Systemen_US
dc.subjectPostoperative Analgesiaen_US
dc.subjectCesareanen_US
dc.subjectSubfacial Infusionen_US
dc.subjectTramadolen_US
dc.titleThe effects of the administration of subfacial levobupivacaine infusion with the ON-Q pain pump system on postoperative analgesia and tramadol consumption in cesarean operationsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu